Suppr超能文献

通过聚合酶链反应-序列特异性引物(PCR-SSP)分型以及随后基于非放射性序列的方法对HLA DRB1/3/4/5、DQB1和DPB1等位基因进行无关骨髓供体的选择。

Selection of unrelated bone marrow donors by PCR-SSP typing and subsequent nonradioactive sequence-based typing for HLA DRB1/3/4/5, DQB1, and DPB1 alleles.

作者信息

Knipper A J, Hinney A, Schuch B, Enczmann J, Uhrberg M, Wernet P

出版信息

Tissue Antigens. 1994 Nov;44(5):275-84. doi: 10.1111/j.1399-0039.1994.tb02396.x.

Abstract

HLA incompatibility between bone marrow recipients and unrelated donors is one of the main obstacles in bone marrow transplantation. HLA class I and generic class II DR and DQ typing is generally performed by serology. Precise subtyping of HLA class II genes, however, can only be achieved by molecular genetic methods. Here, the final selection of serologically pretyped unrelated bone marrow donors by confirmatory PCR-SSP (PCR-sequence-specific primers) typing and subsequent nucleic acid sequence analysis of the second exon of DRB1, DRB3, DRB4, DRB5, DQB1, and DPB1 alleles is presented. Serologically identical potential marrow donors and their corresponding recipients were analyzed for HLA-DRB identity by PCR-SSP analysis. After solid-phase single-strand separation, direct sequencing of the allele- or group-specific DRB amplified products was performed by applying fluorophorlabelled sequencing primers. Electrophoretically separated sequencing products were detected by means of an automated DNA sequencer. Group-specific amplification and sequencing of DQB1 alleles was carried out for all potential bone marrow donors and recipients, while only the final donor-recipient pair was analyzed for DPB1 alleles. Thus, the presented amplification strategy in combination with direct sequencing of PCR products allows matching of bone marrow transplant pairs with the highest degree of reliability for the assessment of HLA class II identity.

摘要

骨髓受体与无关供体之间的HLA不相容性是骨髓移植的主要障碍之一。HLA I类以及通用的II类DR和DQ分型通常通过血清学方法进行。然而,HLA II类基因的精确亚型分型只能通过分子遗传学方法实现。本文介绍了通过验证性PCR-SSP(PCR序列特异性引物)分型以及随后对DRB1、DRB3、DRB4、DRB5、DQB1和DPB1等位基因第二外显子进行核酸序列分析,对血清学预分型的无关骨髓供体进行最终选择的方法。通过PCR-SSP分析,对血清学相同的潜在骨髓供体及其相应受体进行HLA-DRB同一性分析。在固相单链分离后,通过应用荧光标记的测序引物对等位基因或组特异性DRB扩增产物进行直接测序。通过自动DNA测序仪检测电泳分离的测序产物。对所有潜在骨髓供体和受体进行DQB1等位基因的组特异性扩增和测序,而仅对最终的供体-受体对进行DPB1等位基因分析。因此,本文提出的扩增策略与PCR产物的直接测序相结合,能够以最高的可靠性匹配骨髓移植对,用于评估HLA II类同一性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验